Table of Content

1. Global Red Biotechnology Market – Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Red Biotechnology Market Definition
2.2. Red Biotechnology Market Taxonomy
3. Executive Summary : Global Red Biotechnology Market
Market Overview
3.1. Introduction
3.1.1. Definition
3.1.2. Industry Evolution / Developments
3.2. Overview
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restrains
3.3.3. Opportunities
3.4. Global Red Biotechnology Market Analysis and Forecast, 2017–2027
3.5. Market Revenue Projections (US$ Bn)
4. Market Outlook
4.1. Pipeline Analysis
4.2. Mergers & Acquisitions
5. Global Red Biotechnology Market Analysis and Forecast, by Application
5.1. Introduction
5.2. Key Findings / Developments, by Type
5.3. Global Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
5.3.1. Biopharmaceutical Production
5.3.2. Gene Therapy
5.3.3. Pharmacogenomics
5.3.4. Genetic Testing
5.4. Global Red Biotechnology Market Attractiveness Analysis, by Application
6. Global Red Biotechnology Market Analysis and Forecast, by End-user
6.1. Introduction
6.2. Key Findings / Developments, by End-user
6.3. Global Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
6.3.1. Pharmaceutical Industry
6.3.2. CMO & CRO
6.3.3. Research Institutes
6.3.4. Others
6.4. Global Red Biotechnology Market Attractiveness Analysis, by End-user
7. Global Red Biotechnology Market Analysis and Forecast, by Region/sub-Region
7.1. Key Findings / Developments
7.2. Global Red Biotechnology Market Value (US$ Bn) Forecast, by Region/Sub-Region, 2017?2027
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East and Africa (MEA)
7.3. Global Red Biotechnology Market Attractiveness Analysis, by Region/Sub-Region
8. North America Red Biotechnology Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings / Developments
8.2. North America Red Biotechnology Market Value (US$ Bn) Forecast, by Country, 2017?2027
8.2.1. U.S.
8.2.2. Canada
8.3. North America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
8.3.1. Biopharmaceutical Production
8.3.2. Gene Therapy
8.3.3. Pharmacogenomics
8.3.4. Genetic Testing
8.4. North America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
8.4.1. Pharmaceutical Industry
8.4.2. CMO & CRO
8.4.3. Research Institutes
8.4.4. Others
8.5. North America Red Biotechnology Market Attractiveness Analysis
8.5.1. By Country
8.5.2. By Application
8.5.3. By End-user
9. Europe Red Biotechnology Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings / Developments
9.2. Europe Red Biotechnology Market Value (US$ Bn) and Forecast, by Country /Sub-Region, 2017?2027
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. Spain
9.2.5. U.K.
9.2.6. Rest of Europe
9.3. Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
9.3.1. Biopharmaceutical Production
9.3.2. Gene Therapy
9.3.3. Pharmacogenomics
9.3.4. Genetic Testing
9.4. Europe Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
9.4.1. Pharmaceutical Industry
9.4.2. CMO & CRO
9.4.3. Research Institutes
9.4.4. Others
9.5. Europe Red Biotechnology Market Attractiveness Analysis
9.5.1. By Country/Sub-region
9.5.2. By Application
9.5.3. By End-user
10. Asia Pacific Red Biotechnology Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings / Developments
10.2. Asia Pacific Red Biotechnology Market Value (US$ Bn) and Forecast, by Country / Region, 2017?2027
10.2.1. China
10.2.2. India
10.2.3. Japan
10.2.4. Australia and New Zealand
10.2.5. Rest of Asia-Pacific
10.3. Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
10.3.1. Biopharmaceutical Production
10.3.2. Gene Therapy
10.3.3. Pharmacogenomics
10.3.4. Genetic Testing
10.4. Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
10.4.1. Pharmaceutical Industry
10.4.2. CMO & CRO
10.4.3. Research Institutes
10.4.4. Others
10.5. Asia Pacific Red Biotechnology Market Attractiveness Analysis
10.5.1. By Country/Sub-region
10.5.2. By Application
10.5.3. By End-user
11. Latin America Red Biotechnology Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings / Developments
11.2. Latin America Red Biotechnology Market Value (US$ Bn) and Forecast, by Country, 2017?2027
11.2.1. Brazil
11.2.2. Mexico
11.2.3. Rest of Latin America
11.3. Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
11.3.1. Biopharmaceutical Production
11.3.2. Gene Therapy
11.3.3. Pharmacogenomics
11.3.4. Genetic Testing
11.4. Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
11.4.1. Pharmaceutical Industry
11.4.2. CMO & CRO
11.4.3. Research Institutes
11.4.4. Others
11.5. Latin America Red Biotechnology Market Attractiveness Analysis
11.5.1. By Country/Sub-region
11.5.2. By Application
11.5.3. By End-user
12. Middle East & Africa Red Biotechnology Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings / Developments
12.2. Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Country, 2017?2027
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of MEA
12.3. Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
12.3.1. Biopharmaceutical Production
12.3.2. Gene Therapy
12.3.3. Pharmacogenomics
12.3.4. Genetic Testing
12.4. Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
12.4.1. Pharmaceutical Industry
12.4.2. CMO & CRO
12.4.3. Research Institutes
12.4.4. Others
12.5. Middle East & Africa Red Biotechnology Market Attractiveness Analysis
12.5.1. By Country/Sub-region
12.5.2. By Application
12.5.3. By End-user
13. Competition Landscape
13.1. Market Player - Competition Matrix
13.2. Market Share Analysis, by Company (2018)
13.3. Company Profiles
13.3.1. Pfizer, Inc.
13.3.2. Biogen Inc.
13.3.3. Amgen Inc.
13.3.4. AstraZeneca Plc.
13.3.5. Gilead Sciences, Inc.
13.3.6. CELGENE CORPORATION
13.3.7. F. Hoffmann-La Roche, Ltd.
13.3.8. Merck KGaA
13.3.9. Regeneron Pharmaceuticals, Inc.
13.3.10. Takeda Pharmaceutical Company Limited



List of Figures


Figure 01: Global Red Biotechnology Market Value (US$ Bn) Forecast, 2017–2027
Figure 02: Global Red Biotechnology Market Value Share (%), by Application (2018)
Figure 03: Global Red Biotechnology Market Value Share (%), by End -user (2018)
Figure 04: Global Red Biotechnology Market Value Share (%), by Region (2018)
Figure 05: Global Red Biotechnology Market Value Share (%), by Application, 2019 and 2027
Figure 06: Global Red Biotechnology Market Attractiveness, by Application, 2019–2027
Figure 07: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Biopharmaceutical Production 2017–2027
Figure 08: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Gene Therapy 2017–2027
Figure 09: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Pharmacogenomics 2017–2027
Figure 10: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Genetic Testing 2017–2027
Figure 11: Global Red Biotechnology Market Value Share Analysis, by End-user, 2019-2027
Figure 12: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Biopharmaceutical Industry, 2017–2027
Figure 13: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by CMO & CRO, 2017–2027
Figure 14: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Research Institutes, 2017–2027
Figure 15: Global Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 16: Global Red Biotechnology Market Attractiveness Analysis, by End-user, 2019-2027
Figure 17: Global Red Biotechnology Market Value Share Analysis, by Region, 2019 and 2027
Figure 18: Red Biotechnology Market Attractiveness Analysis, by Region, 2019-2027
Figure 19: North America Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 20: North America Red Biotechnology Market Value Share Analysis, by Country, 2019 and 2027
Figure 21: North America Red Biotechnology Market Attractiveness Analysis, by Country, 2019–2027
Figure 22: North America Red Biotechnology Market Value Share (%), by Application, 2019 and 2027
Figure 23: North America Red Biotechnology Market Attractiveness, by Application, 2019–2027
Figure 24: North America Red Biotechnology Market Value Share Analysis, by End-user, 2019-2027
Figure 25: North America Red Biotechnology Market Attractiveness Analysis, by End-user, 2019-2027
Figure 26: Europe Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 27: Europe Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 28: Europe Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 29: Europe Red Biotechnology Market Value Share (%), by Application, 2019 and 2027
Figure 30: Europe Red Biotechnology Market Attractiveness, by Application, 2019–2027
Figure 31: Europe Red Biotechnology Market Value Share Analysis, by End-user, 2019-2027
Figure 32: Europe Red Biotechnology Market Attractiveness Analysis, by End-user, 2019-2027
Figure 33: Asia Pacific Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 34: Asia Pacific Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 35: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 36: Asia Pacific Red Biotechnology Market Value Share (%), by Application, 2019 and 2027
Figure 37: Asia Pacific Red Biotechnology Market Attractiveness, by Application, 2019–2027
Figure 38: Asia Pacific Red Biotechnology Market Value Share Analysis, by End-user, 2019-2027
Figure 39: Asia Pacific Red Biotechnology Market Attractiveness Analysis, by End-user, 2019-2027
Figure 40: Latin America Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 41: Latin America Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 42: Latin America Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 43: Latin America Red Biotechnology Market Value Share (%), by Application, 2019 and 2027
Figure 44: Latin America Red Biotechnology Market Attractiveness, by Application, 2019–2027
Figure 45: Latin America Red Biotechnology Market Value Share Analysis, by End-user, 2019-2027
Figure 46: Latin America Red Biotechnology Market Attractiveness Analysis, by End-user, 2019-2027
Figure 47: Middle East & Africa Red Biotechnology Market Value (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 48: Middle East & Africa Red Biotechnology Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 49: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 50: Middle East & Africa Red Biotechnology Market Value Share (%), by Application, 2019 and 2027
Figure 51: Middle East & Africa Red Biotechnology Market Attractiveness, by Application, 2019–2027
Figure 52: Middle East & Africa Red Biotechnology Market Value Share Analysis, by End-user, 2019-2027
Figure 53: Middle East & Africa Red Biotechnology Market Attractiveness Analysis, by End-user, 2019-2027
Figure 54: Global Red Biotechnology Market Share, by Company, 2018
Figure 55: Pfizer, Inc.’s Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018
Figure 56: Pfizer, Inc.’s Research & Development Expenses (US$ Bn) and Y-o-Y Growth (%), 2016–2018
Figure 57: Pfizer, Inc.’s Revenue (% Share), by Business Segment (2018)
Figure 58: Pfizer, Inc.’s Revenue (% Share), by Region (2018)
Figure 59: Biogen Inc. Breakdown of Net Revenue, by Region 2018
Figure 60: Biogen Inc. Breakdown of Net Sales, By Product, 2018
Figure 61: Biogen Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2018
Figure 62: Biogen Inc. R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2018
Figure 63: Amgen Inc. Business Revenue (US$ Bn) & Y-o-Y Growth (%), 2014 –2018
Figure 64: Amgen Inc. R&D Spending (US$ Bn), 2016- 2018
Figure 65: Amgen Inc. Business Revenue (% Share), by Region, 2018
Figure 66: AstraZeneca Oncology Business Revenue (US$ Bn) & Y-o-Y Growth (%), 2014 –2017
Figure 67: AstraZeneca R&D Oncology Segment Revenue (US$ Bn) & Y-o-Y Growth (%), 2014 –2017
Figure 68: AstraZeneca’s Oncology Business Segment Revenue (% Share), by Region, 2017
Figure 69: Gilead Sciences, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2017
Figure 70: Gilead Sciences, Inc. Breakdown of Net Sales (%), by Products, 2017
Figure 71: Gilead Sciences, Inc. Breakdown of Net Sales (%), by Region, 2017
Figure 72: CELGENE CORPORATION Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
Figure 73: CELGENE CORPORATION Marketing & Sales and R&D Expenses (%), 2015–2017
Figure 74: CELGENE CORPORATION Breakdown of Net Sales (%), by Business Segment, 2018
Figure 75: CELGENE CORPORATION Breakdown of Net Sales (%), by Region, 2018
Figure 76: F. Hoffmann-La Roche, Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014–2018
Figure 77: F. Hoffmann-La Roche, Ltd. Breakdown of Net Sales (%), by Business Segment, 2018
Figure 78: F. Hoffmann-La Roche, Ltd. Breakdown of Net Sales (%), by Region, 2018
Figure 79: Merck KGaA Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2018
Figure 80: Merck KGaA Revenue, by Geography (%), 2018
Figure 81: Merck KGaA Revenue, by Business Segments (%), 2018
Figure 82: Regeneron Pharmaceuticals, Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2018
Figure 83: Regeneron Pharmaceuticals, Inc. Breakdown of Net Sales (%), by Region, 2018
Figure 84: Regeneron Pharmaceuticals, Inc. Breakdown of Net Sales (%), by Product, 2018
Figure 85: CSL Revenue (US$ Bn) & Y-o-Y Growth (%), 2015–2018
Figure 86: CSL Breakdown of Net Sales (%), by Business Segment, 2018
Figure 87: CSL R&D Investment (US$ Bn) & Y-o-Y (%), 2015-2018
Figure 88: Takeda Pharmaceutical Company Limited Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2018
Figure 89: Takeda Pharmaceutical Company Limited Breakdown of Net Sales (%), by Region, 2018
Figure 90: Takeda Pharmaceutical Company Limited R&D Investment (US$ Bn) & Y-o-Y (%), 2015-2018

 

List of Tables


List of Tables


Table 01: Global Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017–2027
Table 02: Global Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
Table 03: Global Red Biotechnology Market Value (US$ Bn) Forecast, by Region, 2017–2027
Table 04: North America Red Biotechnology Market Value (US$ Bn) Forecast, by Country, 2017?2027
Table 05: North America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017–2027
Table 06: North America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
Table 07: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017?2027
Table 08: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017–2027
Table 09: Europe Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
Table 10: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017?2027
Table 11: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017–2027
Table 12: Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
Table 13: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017?2027
Table 14: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017–2027
Table 15: Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
Table 16: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017?2027
Table 17: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017–2027
Table 18: Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027